Therapeutics, Novartis, Pfizer, PUMA Biotechnology, Seattle Genetics, Taiho Pharmaceutical, Zymeworks, outside of the submitted work. R. Bahleda does not have conflicts of interests to disclose. C. Hierro reports grants from Bayer and Merck, has served on the speaker bureau for Merck Sharp & Dohme, and has received travel expenses from Amgen and Merck. M. Sanson reports research support from AstraZeneca, has served on the data and safety monitoring board for Genenta, has served on the advisory board on Abbvie, and has received travel expenses from Abbvie. J. Bridgewater reports advisory board fees from Taiho Pharmaceuticals, outside the submitted work. H-T. Arkenau is an investigator in studies sponsored by Taiho and reports an advisory role in Guardant, Roche, and Servier. B. Tran has served in an advisory role at